Characterization of an inversion on the long arm of chromosome 10 juxtaposing D10S170 and RET and creating the oncogenic sequence RET/PTC
- PMID: 1542652
- PMCID: PMC48503
- DOI: 10.1073/pnas.89.5.1616
Characterization of an inversion on the long arm of chromosome 10 juxtaposing D10S170 and RET and creating the oncogenic sequence RET/PTC
Abstract
RET/PTC is a transforming sequence created by the fusion of the tyrosine kinase domain of the RET protooncogene with the 5' end of the locus D10S170 designated by probe H4 and is frequently found activated in human papillary thyroid carcinomas. RET and D10S170 have been mapped to contiguous regions of the long arm of chromosome 10: q11.2 and q21, respectively. To identify the mechanism leading to the generation of the oncogenic sequence RET/PTC, a combined cytogenetic and molecular analysis of several cases of papillary thyroid carcinomas was done. In four cases the results indicated that these tumors had RET/PTC activation and a paracentric inversion of the long arm of chromosome 10, inv(10)(q11.2q21), with breakpoints coincident with the regions where RET and D10S170 are located. Therefore, a chromosome 10q inversion provides the structural basis for the D10S170-RET fusion that forms the hybrid transforming sequence RET/PTC.
Similar articles
-
Molecular characterization of a thyroid tumor-specific transforming sequence formed by the fusion of ret tyrosine kinase and the regulatory subunit RI alpha of cyclic AMP-dependent protein kinase A.Mol Cell Biol. 1993 Jan;13(1):358-66. doi: 10.1128/mcb.13.1.358-366.1993. Mol Cell Biol. 1993. PMID: 7678053 Free PMC article.
-
A novel multicolor hybridization scheme applied to localization of a transcribed sequence (D10S170/H4) and deletion mapping in the thyroid cancer cell line TPC-1.Cytogenet Cell Genet. 1996;75(4):254-7. doi: 10.1159/000134495. Cytogenet Cell Genet. 1996. PMID: 9067436
-
RET rearrangements in papillary thyroid carcinomas and adenomas detected by interphase FISH.Cytogenet Cell Genet. 2000;88(1-2):56-61. doi: 10.1159/000015485. Cytogenet Cell Genet. 2000. PMID: 10773666
-
[Rearrangement of the RET gene in papillary thyroid carcinoma].Wiad Lek. 2001;54 Suppl 1:64-71. Wiad Lek. 2001. PMID: 12182064 Review. Polish.
-
Cytogenetics and molecular genetics of carcinomas arising from thyroid epithelial follicular cells.Genes Chromosomes Cancer. 1996 May;16(1):1-14. doi: 10.1002/(SICI)1098-2264(199605)16:1<1::AID-GCC1>3.0.CO;2-4. Genes Chromosomes Cancer. 1996. PMID: 9162191 Review.
Cited by
-
High expression of CCDC6 in relation to unfavorable outcome and immune cells infiltration in hepatobiliary carcinoma.J Cancer. 2022 Sep 21;13(12):3378-3395. doi: 10.7150/jca.76050. eCollection 2022. J Cancer. 2022. PMID: 36186907 Free PMC article.
-
The emerging complexity of gene fusions in cancer.Nat Rev Cancer. 2015 Jun;15(6):371-81. doi: 10.1038/nrc3947. Nat Rev Cancer. 2015. PMID: 25998716 Review.
-
FBXO42 activity is required to prevent mitotic arrest, spindle assembly checkpoint activation and lethality in glioblastoma and other cancers.NAR Cancer. 2024 May 20;6(2):zcae021. doi: 10.1093/narcan/zcae021. eCollection 2024 Jun. NAR Cancer. 2024. PMID: 38774470 Free PMC article.
-
The pituitary tumor transforming gene in thyroid cancer.J Endocrinol Invest. 2012 Apr;35(4):425-33. doi: 10.3275/8332. Epub 2012 Apr 5. J Endocrinol Invest. 2012. PMID: 22522436 Review.
-
Identification of sumoylation sites in CCDC6, the first identified RET partner gene in papillary thyroid carcinoma, uncovers a mode of regulating CCDC6 function on CREB1 transcriptional activity.PLoS One. 2012;7(11):e49298. doi: 10.1371/journal.pone.0049298. Epub 2012 Nov 7. PLoS One. 2012. PMID: 23145146 Free PMC article.